Ever since Dranoff et al. engineered GM-CSF-secreting melanoma cell as a potential long-lasting and safe therapy in 1993, GM-CSF-producing oncolytic tumor vaccine has been regarded as a promising therapeutic strategy for various types of cancer [50]. The gene discussed is CSF2; the disease is cancer.